Clinical Trials Browser

OTHER × Efficacy and Safety × irinotecan sucrosofate × Clear all

NCT06383078 2024-04-25

HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer

Phase 2 Not yet recruiting

Efficacy and Safety